StonvexLoading…
StonvexStonvexStonvexCore line items from CBU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-20 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $222.94M | $213.29M | $818.01M | $602.56M | $395.50M |
Operating Income | Not available | $74.61M | $275.39M | $203.47M | $130.31M |
Net Income | Not available | $57.22M | $210.46M | $156.03M | $100.94M |
EPS (Diluted) | $1.18 | $1.08 | $3.97 | $2.94 | $1.90 |
Total Assets | Not available | $17.74B | $17.30B | $16.96B | $16.67B |
Total Liabilities | Not available | $15.72B | $15.30B | $15.02B | $14.78B |
Cash & Equivalents | Not available | $572.17M | $301.75M | $245.25M | $237.25M |
Free Cash Flow OCF − CapEx | Not available | $60.30M | $233.33M | $171.76M | $88.34M |
Shares Outstanding | Not available | 52.78M | 52.82M | 52.85M | 52.88M |